Novel therapy for rheumatoid arthritis using T cell signaling agents.
| Project/Area Number |
24791002
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
膠原病・アレルギー・感染症内科学
|
|---|
| Research Institution | Nagoya City University |
|---|
Principal Investigator |
MAEDA Shinji 名古屋市立大学, 医学(系)研究科(研究院), 助教 (80381854)
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2013: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2012: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
|---|
| Keywords | 関節リウマチ / 制御性Ｔ細胞 / リウマチ / 自己免疫寛容 / 制御性T細胞 / mTOR阻害剤 / IL-2 / 関節炎 / 免疫寛容 / Drug deliverly / 国際情報交換 |
|---|
| Outline of Final Research Achievements |
Regulatory T cells (Tregs) play an important role in self-tolerance, whereas various inflammatory conditions, such as rheumatoid arthritis (RA), attenuate the suppressive function. The purpose of this study is to clarify the modulation of Tregs by agents affecting T cell signaling, providing a basis for novel therapeutic approach for immunological remission.
We have examined the change of phenotypes and the amount of circulating Tregs in human (RA) and mice (BALB/c, Collagen antibody induced arthritis,CAIA) in vivo. In mice, Tregs are increased by mTOR inhibitor (Everolimus) and IL-2CAc (IL-2 cytokine/mIL-2 antibody (JES6-1) complexes). Furthermore, maximum arthritis severity are significantly attenuated by IL-2CAc. In humans with RA, after 4wks CTLA-4-Ig (Abatacept) therapy, the ratio of resting Tregs in CD4 + T cells significantly increased, whereas activated Tregs decreased. Altering T cell signaling using various agents can control Tregs.
|
Report
(4 results)
Research Products
(7 results)
-
-
[Journal Article] The Various Roles of Th17 cells and Th17-related Cytokines in Pathophysiology of Autoimmune Arthritis and Allied Conditions.2013
Author(s)
Maeda, S., Maeda, T., Kobayashi, A., Naniwa, T., & Tamechika, S.
-
Journal Title
Journal of Clinical and Cellular Immunology
Volume: S,10
Issue: S10
Pages: 1-9
DOI
Related Report
Peer Reviewed
-
-
-
-
-
